Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Deakin

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Antibiotics|September 20, 2000
Discovery of novel ansamycins possessing potent inhibitory activity in a cell-based oncostatin M signalling assayP Stead, S Latif, A P Blackaby, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 8, 2014
EPA guidance mental health care of migrantsD Bhugra, S Gupta, M Schouler-Ocak, et al.
Blood|February 28, 2002
Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type IMelissa A Baxter, Robert F Wynn, Jonathan A Deakin, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Antibiotics|September 20, 2000
Discovery of novel ansamycins possessing potent inhibitory activity in a cell-based oncostatin M signalling assayP Stead, S Latif, A P Blackaby, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 8, 2014
EPA guidance mental health care of migrantsD Bhugra, S Gupta, M Schouler-Ocak, et al.
Blood|February 28, 2002
Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type IMelissa A Baxter, Robert F Wynn, Jonathan A Deakin, et al.
Pageof 6